Sort
48,018 grants matching “immunotherapy”
Spatially precise radio-chemo-immunotherapy using antibody conjugates
$533,079Sunil J Advani · University Of California, San Diego · R01 · FY2025 · CA
Spatially precise radio-chemo-immunotherapy using antibody conjugates
$533,079Sunil J Advani · University Of California, San Diego · R01 · FY2023 · CA
Training Program in Immunology
$533,077Gwendalyn J Randolph · Washington University · T32 · FY2022 · AI
CD4 helper programs that regulate intratumoral immunity
$532,970Alice Oliffson Kamphorst · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
IONIC MECHANISMS OF RESISTANCE TO IMMUNOTHERAPY IN HEAD AND NECK CANCER
$532,944Cincinnati Univ Of · · FY2017 · Department of the Army
Tissue Resident memory T cell responses to cancer
$532,934Mary J Turk · Dartmouth College · R01 · FY2021 · CA
Tissue Resident memory T cell responses to cancer
$532,934Mary J Turk · Dartmouth College · R01 · FY2020 · CA
COMBINED EPIGENETIC REPROGRAMMING AND IMMUNOTHERAPY TO TACKLE HIGH-RISK MULTIPLE MYELOMA MODIFICATION P00001 INCORPORATED TRANSFER OF AWARD ON 08/06/25
$532,916Rush University Medical Center · · FY2024 · Defense Health Agency
Stanford Project 2
$532,885Calvin J Kuo · University Of California, San Francisco · U54 · FY2020 · CA
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to blood
$532,816Maki Nakayama · University Of Colorado Denver · R01 · FY2022 · DK
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to blood
$532,816Maki Nakayama · University Of Colorado Denver · R01 · FY2020 · DK
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to blood
$532,816Maki Nakayama · University Of Colorado Denver · R01 · FY2023 · DK
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to blood
$532,816Maki Nakayama · University Of Colorado Denver · R01 · FY2021 · DK
Dysregulated mechanoimmunology of epigenetics-driven lymphomas
$532,624Ankur Singh · Georgia Institute Of Technology · U01 · FY2023 · CA
Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer
$532,609Humam Kadara · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Identifying therapeutic pathways targeting medulloblastoma-immune cell interactions
$532,523Ernest Fraenkel · Massachusetts Institute Of Technology · U01 · FY2023 · CA
Breast Cancer Treatment with Antibody Targeted T Cells
$532,485Roger Williams Hospital · R01 · FY2005 · CA
Antibodies, B cells and resistance to human cryptococcosis
$532,469Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
$532,398John H Sampson · Duke University · P01 · FY2018 · CA
Mechanism(s) of pathogenicity for Candida auris
$532,335Jeniel E Nett · University Of Wisconsin-Madison · R01 · FY2020 · AI
Plasmonic nanoparticle-mediated immunotherapy to treat metastatic cancer
$532,240Tuan Vo-Dinh · Duke University · R01 · FY2020 · EB
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$532,237Lily Yang · Emory University · R01 · FY2023 · CA
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$532,237Lily Yang · Emory University · R01 · FY2022 · CA
Immunologic Monitoring and Cellular Products Laboratory
$532,212Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P30 · FY2019 · CA
Immunologic Monitoring and Cellular Products Laboratory
$532,212Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA